EDGAR Filing Documents for 0001193125-17-045463

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-17-045463

Filing Date

2017-02-15

Accepted

2017-02-15 17:28:39

Documents

114

Period of Report

2016-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	d346875d20f.htm	20-F	3292297
2	EX-8	d346875dex8.htm	EX-8	7157
3	EX-10	d346875dex10.htm	EX-10	2944
4	EX-12.(I)	d346875dex12i.htm	EX-12.(I)	6173
5	EX-12.(II)	d346875dex12ii.htm	EX-12.(II)	9397
6	EX-13	d346875dex13.htm	EX-13	4693
	Complete submission text file	0001193125-17-045463.txt		16890939

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	teva-20161231.xml	EX-101.INS	3794775
8	XBRL TAXONOMY EXTENSION SCHEMA	teva-20161231.xsd	EX-101.SCH	248031
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20161231_cal.xml	EX-101.CAL	166461
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20161231_def.xml	EX-101.DEF	745313
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20161231_lab.xml	EX-101.LAB	1251986
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20161231_pre.xml	EX-101.PRE	1267446

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)